Unknown

Dataset Information

0

Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis.


ABSTRACT:

SUBMITTER: Liu Q 

PROVIDER: S-EPMC8313336 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis.

Liu Qiao Q   Dong Taiwei T   Xi Miaomiao M   Gou Licheng L   Bai Yang Y   Hou Lian L   Li Min M   Ou Li L   Miao Feng F   Wei Peifeng P  

Evidence-based complementary and alternative medicine : eCAM 20210717


<h4>Introduction</h4>Coronary heart disease (CHD) is a common clinical cardiovascular disease, and its morbidity and mortality rates are increasing, which brings a serious burden to the family and society. Dyslipidemia is one of the most important risk factors for CHD. However, it is difficult to reduce blood lipids to an ideal state with the administration of a statin alone. Tongxinluo capsule (TXLC), as a Chinese patent medicine, has received extensive attention in the treatment of CHD in rece  ...[more]

Similar Datasets

| S-EPMC10896841 | biostudies-literature
| S-EPMC9181557 | biostudies-literature
| S-EPMC2596495 | biostudies-other
| S-EPMC11000174 | biostudies-literature
| S-EPMC11753206 | biostudies-literature
| S-EPMC8652334 | biostudies-literature
| S-EPMC7560518 | biostudies-literature
| S-EPMC6200972 | biostudies-other
| S-EPMC8424052 | biostudies-literature
| S-EPMC10789403 | biostudies-literature